Outlook Therapeutics, Inc. Business Finance Contracts & Agreements

83 Contracts & Agreements
Browse by Subcategory
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Form of Note
Note Agreements
Outlook Therapeutics, Inc.
Biotechnology
2025
Securities Purchase Agreement, dated as of January 31, 2025, by and between the Company and Avondale Capital, LLC
Purchase Agreements
Outlook Therapeutics, Inc.
Biotechnology
2025
Form of Syntone Tranche B Inducement Warrant
Warrant Agreements
Outlook Therapeutics, Inc.
Biotechnology
2025
Form of Syntone Tranche A Inducement Warrant
Warrant Agreements
Outlook Therapeutics, Inc.
Biotechnology
2025
Form of Tranche B Inducement Warrant
Warrant Agreements
Outlook Therapeutics, Inc.
Biotechnology
2025
Form of Tranche A Inducement Warrant
Warrant Agreements
Outlook Therapeutics, Inc.
Biotechnology
2025
Third Amendment to Convertible Promissory Note, dated January 22, 2024
Note Agreements
Outlook Therapeutics, Inc.
Biotechnology
2024
Syntone Registration Rights Agreement, dated January 22, 2024
Registration Rights Agreements
Outlook Therapeutics, Inc.
Biotechnology
2024
Syntone Purchase Agreement, dated January 22, 2024
Purchase Agreements
Outlook Therapeutics, Inc.
Biotechnology
NY
2024
Form of Registration Rights Agreement
Registration Rights Agreements
Outlook Therapeutics, Inc.
Biotechnology
2024
Form of Securities Purchase Agreement
Purchase Agreements
Outlook Therapeutics, Inc.
Biotechnology
NY
2024
Form of Syntone Warrant
Warrant Agreements
Outlook Therapeutics, Inc.
Biotechnology
2024
Form of Warrant
Warrant Agreements
Outlook Therapeutics, Inc.
Biotechnology
2024
Amendment, dated December 21, 2023, to the Convertible Promissory Note, dated December 22, 2022, by and between the Company and Streeterville Capital, LLC
Note Agreements
Outlook Therapeutics, Inc.
Biotechnology
2023
Amendment, dated February 10, 2023, to the Convertible Promissory Note, dated December 22, 2022, by and between the Company and Streeterville Capital, LLC
Note Agreements
Outlook Therapeutics, Inc.
Biotechnology
2023
Form of Securities Purchase Agreement, dated as of December 23, 2022, by and between the Company and the Purchasers
Purchase Agreements
Outlook Therapeutics, Inc.
Biotechnology
NY
2022
Form of Warrant
Warrant Agreements
Outlook Therapeutics, Inc.
Biotechnology
2022
Form of Note
Note Agreements
Outlook Therapeutics, Inc.
Biotechnology
UT
2022
Securities Purchase Agreement, dated as of December 22, 2022, by and between the Company and Streeterville Capital, LLC
Purchase Agreements
Outlook Therapeutics, Inc.
Biotechnology
UT
2022
Amended and Restated Investor Rights Agreement, dated April 21, 2022, by and between Outlook Therapeutics, Inc. and GMS Ventures and Investments
Investor Rights Agreements
Outlook Therapeutics, Inc.
Biotechnology
DE
2022
Form of Underwriter Warrant
Warrant Agreements
Outlook Therapeutics, Inc.
Biotechnology
2021
Amended and Restated Underwriting Agreement, dated November 23, 2021, by and between the Company and H.C. Wainwright & Co., LLC
Underwriting Agreements
Outlook Therapeutics, Inc.
Biotechnology
NY
2021
Note Amendment dated November 16, 2021
Note Agreements
Outlook Therapeutics, Inc.
Biotechnology
NY
2021
Promissory Note dated November 16, 2021
Note Agreements
Outlook Therapeutics, Inc.
Biotechnology
NY
2021
Note Purchase Agreement between the Company and Streeterville Capital, LLC, dated as of November 16, 2021
Note Agreements
Outlook Therapeutics, Inc.
Biotechnology
NY
2021
Securities Purchase Agreement, dated February 9, 2021, by and between the Company and GMS Ventures and Investments
Purchase Agreements
Outlook Therapeutics, Inc.
Biotechnology
NY
2021
Securities Purchase Agreement, dated January 28, 2021, by and between the Company and Syntone Ventures LLC
Purchase Agreements
Outlook Therapeutics, Inc.
Biotechnology
NY
2021
Underwriting Agreement, dated January 28, 2021, by and between the Company and H.C. Wainwright & Co., LLC
Underwriting Agreements
Outlook Therapeutics, Inc.
Biotechnology
NY
2021
Promissory Note dated November 4, 2020
Note Agreements
Outlook Therapeutics, Inc.
Biotechnology
NY
2020
Note Purchase Agreement between the Company and Streeterville Capital, LLC, dated as of November 4, 2020
Note Agreements
Outlook Therapeutics, Inc.
Biotechnology
NY
2020
Securities Purchase Agreement, dated June 22, 2020, by and between the Company and Syntone Ventures LLC
Purchase Agreements
Outlook Therapeutics, Inc.
Biotechnology
NY
2020
Form of Securities Purchase Agreement, dated June 22, 2020, by and among the Company and the purchasers named therein
Purchase Agreements
Outlook Therapeutics, Inc.
Biotechnology
NY
2020
Form of Placement Agent Warrant
Warrant Agreements
Outlook Therapeutics, Inc.
Biotechnology
2020
Stock Purchase Agreement, dated May 22, 2020, by and between the Company and Syntone Ventures LLC
Stock Agreements
Outlook Therapeutics, Inc.
Biotechnology
NY
2020
Fourth Amendment to Investor Rights Agreement dated September 11, 2017 by and between the Company and BioLexis Pte. Ltd. (formerly GMS Tenshi Holdings Pte. Limited), by and...
Investor Rights Agreements
Outlook Therapeutics, Inc.
Biotechnology
2020
Securities Purchase Agreement by and between the Company and GMS Ventures and Investments dated February 24, 2020
Purchase Agreements
Outlook Therapeutics, Inc.
Biotechnology
NY
2020
Form of Securities Purchase Agreement, dated February 24, 2020, by and among the Company and the purchasers named therein
Purchase Agreements
Outlook Therapeutics, Inc.
Biotechnology
NY
2020
Form of Placement Agent Warrant
Warrant Agreements
Outlook Therapeutics, Inc.
Biotechnology
2020
Form of GMS Stock Purchase Warrant
Warrant Agreements
Outlook Therapeutics, Inc.
Biotechnology
2020
Form of Common Stock Purchase Warrant
Warrant Agreements
Outlook Therapeutics, Inc.
Biotechnology
2020